Omid Farokhzad

Omid Farokhzad is an American physician-scientist, entrepreneur, and a leading figure in the field of nanomedicine and targeted drug delivery. He is a professor at Harvard Medical School and a physician at Brigham and Women's Hospital, where his research has pioneered the development of smart nanoparticle technologies for treating diseases like cancer. Farokhzad is also a prolific inventor and co-founder of several successful biotechnology companies, translating his laboratory discoveries into clinical therapies. His work has been recognized with numerous prestigious awards, including the Lemelson–MIT Prize.

Early life and education

Omid Farokhzad was born in Tehran, Iran, and immigrated to the United States with his family during his youth. He pursued his undergraduate studies at the University of California, Santa Barbara, where he developed an early interest in the sciences. Farokhzad then earned his M.D. from the Boston University School of Medicine, followed by a residency in anesthesiology at the Massachusetts General Hospital, a major teaching affiliate of Harvard Medical School. His clinical training provided a crucial foundation for his later focus on creating patient-centric therapeutic technologies.

Career and research

Following his clinical training, Farokhzad completed a postdoctoral fellowship in the laboratory of Robert Langer at the Massachusetts Institute of Technology, a collaboration that proved highly influential. His career and research are centered at the intersection of materials science, pharmacology, and clinical medicine. A seminal contribution from his laboratory is the development of targeted nanoparticles that use ligands, such as aptamers or antibodies, to precisely deliver chemotherapeutic drugs to tumor cells while minimizing damage to healthy tissue. This work has advanced the treatment of prostate cancer, ovarian cancer, and other malignancies. He holds numerous patents and has co-founded several companies, including BIND Therapeutics, Selecta Biosciences, and Tarveda Therapeutics, to commercialize these platforms. Farokhzad leads the Laboratory of Nanomedicine and Biomaterials at Brigham and Women's Hospital and holds an appointment at the Harvard-MIT Division of Health Sciences and Technology.

Awards and honors

Farokhzad's innovative contributions have been widely recognized by the scientific and engineering communities. In 2013, he was a co-recipient of the prestigious Lemelson–MIT Prize, often described as the "Oscar for Inventors." He has also received the Ellison Medical Foundation Award for his work in aging-related research. His achievements have been acknowledged by his election as a Fellow of the American Institute for Medical and Biological Engineering and as a member of the National Academy of Inventors. Further honors include the Biotechnology Industry Organization’s Emerging Company Award and being named a "Top 20 Translational Researcher" by the journal Nature Biotechnology.

Selected publications

Farokhzad has authored over 150 peer-reviewed scientific papers and book chapters. Key publications that have shaped the field include a landmark 2004 paper in Cancer Research on aptamer-functionalized nanoparticles, a 2006 study in the PNAS detailing targeted delivery to prostate cancer, and a 2010 article in Nature Nanotechnology on the clinical translation of nanomedicines. His highly cited work also encompasses reviews in major journals like Chemical Reviews and Science Translational Medicine, which have helped define the roadmap for nanoparticle-based drug development.

Personal life

Omid Farokhzad maintains a private personal life, with limited public information available about his family. He is known to be deeply committed to mentoring the next generation of scientists and physician-innovators at Harvard University and beyond. His journey from Iran to becoming a leading figure in American biotechnology and academia is frequently cited as an inspiration for aspiring researchers from diverse backgrounds. He actively participates in initiatives aimed at fostering entrepreneurship and innovation within the life sciences sector.

Category:American medical researchers Category:Harvard Medical School faculty Category:Biotechnology entrepreneurs Category:1966 births Category:Living people